Benutzer: Gast  Login
Dokumenttyp:
journal article 
Autor(en):
Polman, CH; Bertolotto, A; Deisenhammer, F; Giovannoni, G; Hartung, HP; Hemmer, B; Killestein, J; McFarland, HF; Oger, J; Pachner, AR; Petkau, J; Reder, AT; Reingold, SC; Schellekens, H; Sørensen, PS 
Titel:
Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis. 
Abstract:
The identification of factors that can affect the efficacy of immunomodulatory drugs in relapsing-remitting multiple sclerosis (MS) is important. For the available interferon-beta products, neutralising antibodies (NAb) have been shown to affect treatment efficacy. In June, 2009, a panel of experts in MS and NAbs to interferon-beta therapy convened in Amsterdam, Netherlands, under the auspices of the Neutralizing Antibodies on Interferon beta in Multiple Sclerosis consortium, a European-based pr...    »
 
Zeitschriftentitel:
Lancet Neurol 
Jahr:
2010 
Band / Volume:
Heft / Issue:
Seitenangaben Beitrag:
740-50 
Sprache:
eng 
Print-ISSN:
1474-4422 
TUM Einrichtung:
Neurologische Klinik und Poliklinik